Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

148 results
Display

The Effect of Long-Term Sodium-Glucose Cotransporter 2 Inhibitor Treatment on Renal Function in Patients with Type 2 Diabetes

Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

Chronic kidney disease commonly develops in patients with type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement

Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Lee DW, Moon MK, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changing Treatment Paradigm of Type 2 Diabetes

Hur KY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement

Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Moon MK, Lee DW, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Long-term Sodium-glucose Cotransporter 2 Inhibitor Treatment on Renal Function in the Patients with Type 2 Diabetes

Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY

Chronic kidney disease is developed commonly in type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study

Bae JC, Cho NH, Kim JH, Hur KY, Jin SM, Lee MK

Background: Type 2 diabetes and cardiovascular disease (CVD) are the most important sequelae of obesity and the leading cause of death. We evaluated the association between body mass index (BMI)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolic Outcomes of Surgery for Non-Obese Type 2 Diabetes

Hur KY

The most plausible contributing factor to non-obese type 2 diabetes may be imbalanced incretin release from the intestinal epithelium in response to nutrients. Rerouting intestinal continuity through bypass surgery to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment (Diabetes Metab J 2020;44:56-66)

Park SW, Lee S, Cha WC, Hur KY, Kim JH, Lee MK, Park SM, Jin SM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement

Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS, Committee of Clinical Practice Guidelines, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Initial Experience with Laparoscopic Loop Duodenojejunal Bypass with Sleeve Gastrectomy in Korean Obese Patients

Kim SH, Hur KY, Chung Y, Kim YJ

Laparoscopic loop duodenojejunal bypass with sleeve gastrectomy (LDJB-SG) has theoretical advantages compared with laparoscopic Roux-en-Y gastric bypass. We performed 7 cases of LDJBSG from May 2019 to September 2019. All...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment

Park SW, Lee S, Cha WC, Hur KY, Kim JH, Lee MK, Park SM, Jin SM

BACKGROUND: We aimed to describe the outcome of a computerized intravenous insulin infusion (CII) protocol integrated to the electronic health record (EHR) system and to improve the CII protocol in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement

Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS, Committee of Clinical Practice Guidelines, Korean Diabetes Association, Committee of the Cooperative Studies, Korean Society of Nephrology

The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status of Proficiency Testing Programs and Development of Reference Materials for Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Diagnostic Tests

Hur KH, Park K, Yang JJ, Kim MN, Sung H

Laboratory preparedness and rapid expansion of testing capacity are essential for controlling the coronavirus disease 2019 (COVID-19) outbreak. Such efforts require the prompt implementation of authorized emergencyuse test kits and extensive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Causes and Clinical Relevance of Inconclusive SARS-CoV-2 Real-Time Reverse TranscriptionPCR Test Results

Kim A, Lee H, Hur KW, Sung H, Kim MN

Background: Inconclusive SARS-CoV-2 real-time reverse transcription-PCR (rRT-PCR) test results, which are positive for one or more target genes but not all, are problematic in clinical laboratories. In this study, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quality of Ribonucleic Acid Extraction for Real-Time Reverse Transcription-PCR (rRT-PCR) of SARS-CoV-2: Importance of Internal Control Monitoring

Lee YJ, Lim Y, Hur KW, Sung H, Kim MN

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial

Lee SE, Choi Y, Jun JE, Lee YB, Jin SM, Hur KY, Ko GP, Lee MK

BACKGROUND: Metformin, sulfonylurea, and dietary fiber are known to affect gut microbiota in patients with type 2 diabetes mellitus (T2DM). This open and single-arm pilot trial investigated the effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea

Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS, Committee of Clinical Practice Guidelines, Korean Diabetes Association

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study

Hwang YC, Kim SW, Hur KY, Cha BS, Kim IJ, Park TS, Baik SH, Yoon KH, Lee KW, Lee IK, Lee MK

BACKGROUND: Removal of uremic toxins such as indoxyl sulfate by AST-120 is known to improve renal function and delay the initiation of dialysis in patients with advanced chronic kidney disease....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis of Peripheral Artery Disease: Focus on the 2016 American Heart Association/American College of Cardiology and 2017 European Society of Cardiology Guidelines

Hur KY

Peripheral artery disease (PAD) is the most frequent cause of reduced perfusion in peripheral arteries. Patients with PAD often have manifestations of atherosclerosis of the lower limb, although both symptomatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Centromere Protein-F-like Pattern in a Patient With Rheumatoid Arthritis

Hur K, Jearn LH, Kim TY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr